The European Alliance of Associations for Rheumatology - held its 2026 annual Congress in London, where gout was high on the ...
Read new insights in urate-lowering therapy in a treat-to-target strategy for gout management, heard at EULAR 2026.
Crystalys Therapeutics has dosed the first patient with its once daily oral, URAT1 inhibitor dotinurad in its Phase II AMETHYST trial (NCT07535034), designed to assess dotinurad’s effectiveness in ...
Addition of VENCLYXTO plus acalabrutinib, with or without obinutuzumab, and VENCLYXTO plus ibrutinib supported by data from Phase 3 AMPLIFY trial, Phase 3 GLOW trial and Phase 2 CAPTIVATE trial ...
Use ice packs on the sore joint for 15 to 20 minutes to quickly reduce pain and swelling. Drink lots of water to help flush out uric acid and prevent kidney stones. Taking nonsteroidal ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results